ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC13934-200μg |
|
125580-28-1 |
[Leu31,Pro34]-Neuropeptide Y (porcine)
|
0 | C190H286N54O56 | |
GC13932-100mg |
|
120279-96-1 |
Dorzolamide
|
0 | C10H16N2O4S3 | |
GC13932-50mg |
|
120279-96-1 |
Dorzolamide
|
0 | C10H16N2O4S3 | |
GC13932-10mg |
|
120279-96-1 |
Dorzolamide
|
0 | C10H16N2O4S3 | |
GC13931-50mg |
|
22260-51-1 |
Bromocriptine mesylate
|
0 | C32H40BrN5O5.CH3SO3H | |
GC13930-10mM (in 1mL DMSO) |
|
110683-10-8 |
N-(p-amylcinnamoyl) Anthranilic Acid
|
0 | C21H23NO3 | |
GC13930-100mg |
|
110683-10-8 |
N-(p-amylcinnamoyl) Anthranilic Acid
|
0 | C21H23NO3 | |
GC13930-50mg |
|
110683-10-8 |
N-(p-amylcinnamoyl) Anthranilic Acid
|
0 | C21H23NO3 | |
GC13930-25mg |
|
110683-10-8 |
N-(p-amylcinnamoyl) Anthranilic Acid
|
0 | C21H23NO3 | |
GC13928-10mM (in 1mL DMSO) |
|
173529-46-9 |
HMN-214
|
0 | C22H20N2O5S | |
GC13928-50mg |
|
173529-46-9 |
HMN-214
|
0 | C22H20N2O5S | |
GC13928-10mg |
|
173529-46-9 |
HMN-214
|
0 | C22H20N2O5S | |
GC13928-5mg |
|
173529-46-9 |
HMN-214
|
0 | C22H20N2O5S | |
GC13927-10mM (in 1mL DMSO) |
|
607737-87-1 |
A 77-01
|
0 | C18H14N4 | |
GC13927-25mg |
|
607737-87-1 |
A 77-01
|
0 | C18H14N4 | |
GC13927-10mg |
|
607737-87-1 |
A 77-01
|
0 | C18H14N4 | |
GC13926-10mg |
|
445430-58-0 |
BMS-345541(free base)
|
0 | C14H17N5 | |
GC13926-50mg |
|
445430-58-0 |
BMS-345541(free base)
|
0 | C14H17N5 | |
GC13926-5mg |
|
445430-58-0 |
BMS-345541(free base)
|
0 | C14H17N5 | |
GC13925-10mg |
|
300816-11-9 |
Nullscript
|
0 | C16H14N2O4 | |